UBS AM’s Kymera Therapeutics KYMR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $48.9M | Buy |
|
|||||
|
2025
Q2 | $35.7M | Sell |
|
|||||
|
2025
Q1 | $24.5M | Buy |
|
|||||
|
2024
Q4 | $16.3M | Sell |
|
|||||
|
2024
Q3 | $20.3M | Sell |
|
|||||
|
2024
Q2 | $12.9M | Buy |
|
|||||
|
2024
Q1 | $7.23M | Buy |
|
|||||
|
2023
Q4 | $4.49M | Sell |
|
|||||
|
2023
Q3 | $2.64M | Buy |
|
|||||
|
2023
Q2 | $5.23M | Hold |
|
|||||
|
2023
Q1 | $5.23M | Sell |
|
|||||
|
2022
Q4 | $4.48M | Buy |
|
|||||
|
2022
Q3 | $3.65M | Sell |
|
|||||
|
2022
Q2 | $3.83M | Sell |
|
|||||
|
2022
Q1 | $18.2M | Buy |
|
|||||
|
2021
Q4 | $16.9M | Sell |
|
|||||
|
2021
Q3 | $15.6M | Sell |
|
|||||
|
2021
Q2 | $13.7M | Buy |
|